Glucocorticoids: Clinical Trials

37 trials of Glucocorticoids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 6 recruiting, 5 unknown, 4 not yet recruiting. 37 Phase 2, 8 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 237Completed 18, Recruiting 6, Unknown 5, Not yet recruiting 4, Active not recruiting 2, Terminated 2
Phase 38Completed 6, Not yet recruiting 1, Unknown 1
Phase 15Completed 2, Not yet recruiting 2, Unknown 1

Follow Glucocorticoids: new trials by email Literature Review of Glucocorticoids trials Research Report on Glucocorticoids

Trials (filtered) newest first · largest first

All 37 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period
Arumakimig, Placebo, Oral glucocorticoids - VEXAS Syndrome
Phase 2RecruitingNovartis Pharmaceuticals1202026-10-302026-11-09
Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis
Obinutuzumab beta, Glucocorticoids - ANCA-Associated Glomerulonephritis (AAGN), ANCA-Associated Vasculitis (AAV)
Phase 2RecruitingChinese PLA General Hospital202026-08-212026-09-15
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Momelotinib, Glucocorticoids, Placebo - VEXAS Syndrome
Phase 2 / Phase 3Not yet recruitingGlaxoSmithKline1362026-08-052026-06-01
Bosentan in the Treatment of Giant Cell Arteritis
Bosentan, Glucocorticoids - Giant Cell Arteritis (GCA)
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris402026-06-012026-05-06
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Glucocorticoids, belimumab, Telitacicept - Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Phase 2RecruitingNanjing University School of Medicine502025-12-082026-03-12
A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.
CM313 (SC), Glucocorticoids - Pemphigus Disease, Pemphigus Vulgaris (PV)
Phase 1 / Phase 2Not yet recruitingChao Ji1002025-10-012024-10-29
Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Homoharringtonine, BCL-2 inhibitor, CD20 Antibody - Diffuse Large B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma
Phase 1 / Phase 2Not yet recruitingFirst Affiliated Hospital of Zhejiang University622025-09-082025-09-08
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Rapcabtagene autoleucel, Active Comparator, Glucocorticoids - ANCA Associated Vasculitis (AAV)
Phase 2Active not recruitingNovartis Pharmaceuticals1262025-03-132026-09-04
A Clinical Trial With KJ103 in Anti-GBM Disease
KJ103 for Injection, Cyclophosphamide, Glucocorticoids - Anti-Glomerular Basement Membrane Disease
Phase 2Active not recruitingShanghai Bao Pharmaceuticals Co., Ltd.122024-10-212025-06-13
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Adalimumab, Prednisone - Inflammatory Arthritis, Immune-related Adverse Event
Phase 2RecruitingTom Appleton302024-04-152026-03-03
Rescue of Nephrons With ALE.F02 (RENAL-F02)
ALE.F02, Rituximab, GlucoCorticoid - Glomerulonephritis Rapidly Progressive
Phase 2RecruitingAlentis Therapeutics AG802023-09-072026-08-14
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
JYP0061, Intravenous Glucocorticoids, Oral Glucocorticoids - Neuromyelitis Optica Spectrum Disorders
Phase 2RecruitingGuangzhou JOYO Pharma Co., Ltd352023-05-242024-11-20
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Nipocalimab, Placebo, Glucocorticoids - Myositis
Phase 2CompletedJanssen Research & Development, LLC362022-07-052026-11-04
Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
BDB-001 injection, Cyclophosphamide, Glucocorticoids - ANCA-associated Vasculitis
Phase 1 / Phase 2CompletedStaidson (Beijing) Biopharmaceuticals Co., Ltd932022-02-222025-08-07
A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154
ABBV-154, Placebo, Glucocorticoid - Polymyalgia Rheumatica
Phase 2TerminatedAbbVie1812021-09-092024-10-15
MSC for Treatment of cGVHD After Allo-HSCT
Mesenchymal stem cells, Glucocorticoids, cyclosporine - Chronic Graft-versus-host Disease
Phase 2UnknownNanfang Hospital, Southern Medical University1522021-01-102020-12-31
Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
rilzabrutinib, Glucocorticoids - Immunoglobulin G4 Related Disease
Phase 2CompletedPrincipia Biopharma, a Sanofi Company272020-08-222025-10-14
Twice Weekly Steroids and Exercise as Therapy for DMD
Prednisone, Exercise Training on standard steroid regimen, Exercise training on twice-weekly steroids - Duchenne Muscular Dystrophy (DMD)
Phase 2CompletedUniversity of Florida212020-07-302026-03-13
Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
IFX-1, Placebo-IFX-1, Glucocorticoid (GC) - Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA)
Phase 2CompletedInflaRx GmbH572019-04-032022-08-25
Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
Tocilizumab, Glucocorticoids - Giant Cell Arteritis
Phase 1 / Phase 2CompletedInsel Gruppe AG, University Hospital Bern182018-12-012021-06-22

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (4)  ·  Aspergillosis, Allergic Bronchopulmonary (4)  ·  Giant Cell Arteritis (3)  ·  Anemia (2)  ·  Anemia, Aplastic (2)  ·  Anemia, Hemolytic (2)  ·  Arthritis (2)  ·  Bone Marrow Failure Disorders (2)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Granulomatosis with Polyangiitis (2)  ·  Hematologic Diseases (2)  ·  Hemoglobinuria (2)  ·  Hemoglobinuria, Paroxysmal (2)  ·  Microscopic Polyangiitis (2)  ·  Proteinuria (2)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (4)  ·  Insel Gruppe AG, University Hospital Bern (2)  ·  Institute of Hematology & Blood Diseases Hospital, China (2)  ·  Nanfang Hospital, Southern Medical University (2)  ·  Novartis Pharmaceuticals (2)  ·  AbbVie (1)  ·  Alentis Therapeutics AG (1)  ·  Amgen (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Chao Ji (1)  ·  Chinese Academy of Medical Sciences (1)  ·  Chinese PLA General Hospital (1)  ·  Cougar Biotechnology, Inc. (1)  ·  First Affiliated Hospital of Zhejiang University (1)

Countries

China (12)  ·  United States (8)  ·  France (6)  ·  United Kingdom (6)  ·  Canada (5)  ·  Germany (5)  ·  Italy (5)  ·  Spain (5)  ·  Switzerland (5)  ·  India (4)  ·  Japan (4)  ·  Czechia (3)  ·  Denmark (2)  ·  Hungary (2)  ·  Netherlands (2)

Top investigators

Ritesh Agarwal, MD, DM (2)  ·  Anja Pfaff, PhD (1)  ·  Christian Larsen, MD (1)  ·  Chunhua Zhao, MD,PHD (1)  ·  Cougar Biotechnology, Inc. Clinical Trial (1)  ·  Flavio Vincenti, MD (1)  ·  He Huang, MD (1)  ·  Jan Frystyk, Professor (1)  ·  Juergen Braun, MD (1)  ·  Kunshen Liu, MD (1)  ·  Laimonas Griskevicius, MD (1)

Results publications

PMID 21802835, PMID 26585431, PMID 26952547, PMID 28388956, PMID 28945869, PMID 29331473, PMID 29961816, PMID 30561849, PMID 31260678, PMID 31668569, PMID 31671877, PMID 33128347, PMID 34117737, PMID 37287970, PMID 38287611

NIH funding

2018 (1), 2023 (1), 2025 (1)